Kohlberg Kravis Roberts & Co. L.P.

Holdings History for BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Symbol: BBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	16%	0%	$1,014,331,672	13,260,971	0		$76.49	Q4 2025
30 Sep 2025	12%	0%	$688,774,834	13,260,971	0		$51.94	Q3 2025
30 Jun 2025	12%	-5.4%	$572,608,728	13,260,971	-6,000,000	-31%	$43.18	Q2 2025
31 Mar 2025	15%	-4.7%	$665,851,767	19,260,971	-6,000,000		$34.57	Q1 2025
31 Dec 2024	19%	0%	$693,161,044	25,260,971	0		$27.44	Q4 2024
30 Sep 2024	8.6%	-2%	$643,144,322	25,260,971	-5,800,000	-19%	$25.46	Q3 2024
30 Jun 2024	24%	0%	$786,774,395	31,060,971	0		$25.33	Q2 2024
31 Mar 2024	25%	0%	$960,405,223	31,060,971	0		$30.92	Q1 2024
31 Dec 2023	37%	0%	$1,253,931,399	31,060,971	0		$40.37	Q4 2023
30 Sep 2023	29%	0%	$819,077,805	31,060,971	0		$26.37	Q3 2023
30 Jun 2023	17%	0%	$534,248,701	31,060,971	0		$17.20	Q2 2023
31 Mar 2023	16%	0%	$514,990,899	31,060,971	0		$16.58	Q1 2023
31 Dec 2022	8%	0%	$236,684,599	31,060,971	0		$7.62	Q4 2022
30 Sep 2022	6.2%	0%	$308,746,000	31,060,971	0		$9.94	Q3 2022
30 Jun 2022	3.7%	0%	$282,034,000	31,060,971	0		$9.08	Q2 2022
31 Mar 2022	2.9%	0%	$315,269,000	31,060,971	0		$10.15	Q1 2022
31 Dec 2021	2.8%	0%	$518,097,000	31,060,971	0		$16.68	Q4 2021
30 Sep 2021	7.3%	0%	$1,455,828,000	31,060,971	0		$46.87	Q3 2021
30 Jun 2021	7.7%	0%	$1,893,477,000	31,060,971	0		$60.96	Q2 2021
31 Mar 2021	9.6%	-1.1%	$1,913,356,000	31,060,971	-3,450,000	-10%	$61.60	Q1 2021
31 Dec 2020	12%	0%	$2,454,075,000	34,510,971	0		$71.11	Q4 2020
30 Sep 2020	7.5%	0%	$1,294,852,000	34,510,971	0		$37.52	Q3 2020
30 Jun 2020	6.9%	-0.48%	$1,125,403,000	34,510,971	-2,389,690	-6.5%	$32.61	Q2 2020
31 Mar 2020	6.8%	0%	$1,070,119,000	36,900,661	0		$29.00	Q1 2020
31 Dec 2019	6.3%	0%	$1,293,368,000	36,900,661	0		$35.05	Q4 2019
30 Sep 2019	4.5%	0%	$792,257,000	36,900,661	0		$21.47	Q3 2019
30 Jun 2019	12%	+12%	$995,211,000	36,900,661	+36,900,661	NEW	$26.97	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.